The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 Cell Therapeutics Inc  (CTIC) Trade Now »     Rate CTIC  -  Discuss CTIC  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
SocialPicks Sentiment:

** v.s. other stocks 		This Quarter's Sentiment:
All:
61.5%
Top:
20.0%
Rate CTIC:


Home
Analysis & Videos
Quotes
Bull or Bear
Discuss
        

CTIC: Bull or Bear? From:    SocialPicks  |  Blogsphere  |  All

SocialPicks Community

200ma - stock retraced to 200ma now! Graphic_rating_buy CTIC
Avatar_1619
N/A
it is at support and ready to take off again. 
By  gator-trader   (-9.91%  risk: conservative)  11/12/09 2 comments


BioMed Momentum Index: Pause that Refreshes or More Pain to Come? Graphic_rating_sell CTIC
Mikerun
73%
Below is a 10-stock BioMed Momentum Index that I have created along with related financial data from Google Finance as of 10/28/09, including the stock price, 52-week change, average daily trading volume, and market cap. I have screened for small and micro-cap stocks with market caps of approximately $500 million (M) or lower with stock price increases of at least 50% in the past year and average trading volume of at least 1M shares per day.
 
 
<> 1.) Antigenics (NASDAQ: AGEN) ($...
By  Mike Havrilla   (+1.04%  risk: conservative)  10/29/09 Comment


Bullish on CTIC Graphic_rating_buy CTIC
N/A
CTIC should bullish based on technical analysis and recent news.
By  chlim   (-0.90%  risk: conservative)  10/10/09 1 comment


Short Cell Therapeutics, Inc (CTIC) Graphic_rating_sell CTIC
Stock_picks_expert
N/A
Insiders are selling
Revenues are down
EPS are down
CTIC underperform compare with the market last 3m
Make Money -  http://www.money-top10.com/
Investments - http://www.stockpicksexpert.com/


Cell Therapeutics, Inc., a biopharmaceutical company, develops, acquires,
and commercializes oncology products for cancer treatment. Its development
portfolio includes Pixantrone, a phase III trial product, for non-Hodgkin?s
lymphoma; Brostallicin, which is in first-line Phase II study for the treatment
of sarcoma; and OPAXIO, a chemotherapeuti...
By  stockexpert   (+2.47%  risk: conservative)  09/26/09 4 comments


CTIC has to move soon Graphic_rating_buy CTIC
N/A
This is a stock that sold near $400.00 at one time and now is looking forward to a lot of positive news at $1.50.  I continue to sell other stocks to buy CTIC and FTWR.
By  legan   (+2.83%  risk: conservative)  08/13/09 1 comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.25% 381
2 Gerald Greene 18.14 +72.34% 210
3 stockmarketfunding.com 17.66 +25.65% 55
4 akiralegrand 13.47 +14.32% 61
5 anup2104 12.13 +76.91% 39


POPULAR STOCKS
Symbol Company Name Sentiment
GM General Motors Corp
GLD streetTRACKS Gold
ETFC E*Trade Financial Corp
C Citigroup Inc
SIRI Sirius Satellite Radio Inc
YHOO Yahoo! Inc

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on CTIC

Visit streetinsider.com


Discussion Wall + Add  
amritadas   (+0.00%)
A FREE report on the approval of a new Gout Drug - An upcoming treatment by a small cap company for Gout to face FDA decision on approval shortly. Gout has traditionally been a difficult disease to tre
+   0 replies

stock_analyzer   (+0.00%  risk: conservative)
Chart Alerts for April 14 - Here is a link to some chart alerts for April 14th http://www.stockhideout.com/sas-nightly-chart-scans/2809-chart-alerts-april-14-a.html
+   0 replies


More Resources

Graphic_arrow1 About Cell Therapeutics Inc - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch